{"id":222863,"date":"2026-08-31T09:31:33","date_gmt":"2026-08-31T04:01:33","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=222863"},"modified":"2026-08-31T09:31:33","modified_gmt":"2026-08-31T04:01:33","slug":"why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/","title":{"rendered":"Glenmark Life Sciences Ltd. (ALIVUS) Share Price Rises 6.12% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\">Glenmark Life Sciences Ltd. (ALIVUS)<\/a> share price rose to Rs 1,433.95 today, up 6.12% from the previous close. Market cap was Rs 16,589.49 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 31 August 2026 at 9:19:50 AM IST<\/p>\n<p style=\"margin-top:0!important;\">ALIVUS Share Price rose to Rs 1,433.95, up 6.12% from the previous close of Rs 1,351.25, with market capitalisation at Rs 16,589.49 crore. The move placed Glenmark Life Sciences Ltd. among the stocks in news today, and the ALIVUS share price update is relevant because the session also printed an intraday high of Rs 1,433.95 and turnover of Rs 0.47 crore. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking ALIVUS Share Price Today, the most useful next checks are the valuation backdrop, sector benchmark and whether the share price rise remains aligned with the broader healthcare peer set on Univest.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#ALIVUS_Share_Price_Today_Price_Action_Analysis\" title=\"ALIVUS Share Price Today: Price Action Analysis\">ALIVUS Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Glenmark_Life_Sciences_Ltd_ALIVUS_Fundamental_Analysis\" title=\"Glenmark Life Sciences Ltd. (ALIVUS) Fundamental Analysis\">Glenmark Life Sciences Ltd. (ALIVUS) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Why_Investors_Are_Watching_ALIVUS\" title=\"Why Investors Are Watching ALIVUS\">Why Investors Are Watching ALIVUS<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#About_Glenmark_Life_Sciences_Ltd\" title=\"About Glenmark Life Sciences Ltd.\">About Glenmark Life Sciences Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Track_ALIVUS_Share_Price_on_Univest\" title=\"Track ALIVUS Share Price on Univest\">Track ALIVUS Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Why_did_ALIVUS_Share_Price_rise_today\" title=\"Why did ALIVUS Share Price rise today?\">Why did ALIVUS Share Price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#What_is_the_current_ALIVUS_Share_Price\" title=\"What is the current ALIVUS Share Price?\">What is the current ALIVUS Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#What_is_the_market_capitalisation_of_Glenmark_Life_Sciences_Ltd\" title=\"What is the market capitalisation of Glenmark Life Sciences Ltd.?\">What is the market capitalisation of Glenmark Life Sciences Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#How_does_ALIVUS_look_on_valuation\" title=\"How does ALIVUS look on valuation?\">How does ALIVUS look on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#How_strong_are_the_profitability_ratios_for_ALIVUS\" title=\"How strong are the profitability ratios for ALIVUS?\">How strong are the profitability ratios for ALIVUS?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#How_does_ALIVUS_compare_with_its_peers\" title=\"How does ALIVUS compare with its peers?\">How does ALIVUS compare with its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-life-sciences-ltd-share-price-price-rise-2026-08-31\/#Can_investors_track_ALIVUS_Share_Price_on_Univest\" title=\"Can investors track ALIVUS Share Price on Univest?\">Can investors track ALIVUS Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"ALIVUS_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>ALIVUS Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,433.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,351.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 82.7 (+6.12%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,251<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,433.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,251<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.47 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,589.49 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) rose to Rs 1,433.95 from the previous close of Rs 1,351.25, a move of Rs 82.7 or 6.12%. The stock opened at Rs 1,251, reached a high of Rs 1,433.95, recorded a low of Rs 1,251.<\/p>\n<p>ALIVUS Share Price opened at Rs 1,251, touched a day low of Rs 1,251 and finished at the day high of Rs 1,433.95. That means the stock rose Rs 82.70, or 6.12%, versus the previous close of Rs 1,351.25. The move was clean within the day\u2019s range because the close matched the high and the low matched the open. In stock market today terms, Glenmark Life Sciences Ltd. stood out as a rising today name without any verified company-specific trigger in the supplied data. Investors following ALIVUS Stock News can therefore focus on the measured price action, current valuation and sector context rather than an unverified headline cause. Univest tracks the same session move in a structured way for readers who want a concise ALIVUS Share Price summary.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Life_Sciences_Ltd_ALIVUS_Fundamental_Analysis\"><\/span><strong>Glenmark Life Sciences Ltd. (ALIVUS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,589.49 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 49.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 283.86<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.37%<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) fundamental metrics show P\/E 27.51x, P\/B 4.76x, ROE 18.41%, ROCE 24.61%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Glenmark Life Sciences Ltd. has a market capitalisation of Rs 16589.49 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 27.51x, P\/B at 4.76x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.41% and ROCE of 24.61%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 49.12, book value per share of Rs 283.86, dividend yield of 0.37%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.7x to 672.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,589.49 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 670.73 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a P\/E ratio of 27.51x, which is below the benchmark median of 31.21x, a difference of -11.86%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a ROE of 18.41%, which is above the benchmark median of 11.78%, a difference of +56.28%. Glenmark Life Sciences Ltd. (ALIVUS) has a ROCE of 24.61%, which is above the benchmark median of 13.6%, a difference of +80.96%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Life Sciences Ltd. (ALIVUS) has a P\/E ratio of 27.51x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.41% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.61% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glenmark Life Sciences Ltd. (ALIVUS) has a market capitalisation of Rs 16,589.49 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_ALIVUS\"><\/span><strong>Why Investors Are Watching ALIVUS<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>ALIVUS Share Price rose 6.12% today to Rs 1,433.95, with the close at the day high.<\/li>\n<li>Market capitalisation stands at Rs 16,589.49 crore, placing Glenmark Life Sciences Ltd. above the industry median.<\/li>\n<li>P\/E is 27.51 and P\/B is 4.76, which gives ALIVUS Share Price a clear valuation frame.<\/li>\n<li>ROE of 18.41% and ROCE of 24.61% are both above the same-industry median.<\/li>\n<li>Turnover was Rs 0.47 crore, and the session move is visible without a verified company-specific catalyst.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glenmark_Life_Sciences_Ltd\"><\/span><strong>About Glenmark Life Sciences Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glenmark Life Sciences Ltd., now tracked on the market as ALIVUS, operates in the Pharmaceuticals &#038; Drugs industry within Healthcare. The company\u2019s listing context places it in a sector where investors often compare profitability, valuation and scale across a wide set of peers. Based on the supplied data, the business should be viewed through its market capitalisation, earnings profile and industry benchmark rather than through a narrow price move alone. For readers following ALIVUS Share Price, the company overview is best understood alongside its current financial ratios: EPS of Rs 49.12, book value of Rs 283.86 and dividend yield of 0.37%. Univest uses that same fact base to keep ALIVUS Stock News and ALIVUS Company News tied to measurable market data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_ALIVUS_Share_Price_on_Univest\"><\/span><strong>Track ALIVUS Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\">Glenmark Life Sciences Ltd. (ALIVUS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Readers can track ALIVUS Share Price on Univest for live share price, fundamental ratios, shareholding pattern, 52-week levels and broader market insights. The platform also helps compare ALIVUS Stock Analysis with peer benchmarks, sector context and market cap data in one place. If you are following ALIVUS Share Price Today, Univest keeps the latest data organised for quick review. That makes it easier to monitor ALIVUS Share Price Live, ALIVUS Share News and ALIVUS Latest News without losing the financial context behind the day\u2019s move.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_ALIVUS_Share_Price_rise_today\"><\/span><strong>Why did ALIVUS Share Price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms a 6.12% rise to Rs 1,433.95, but it does not establish a company-specific catalyst. The move is still useful to track because the close matched the intraday high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_ALIVUS_Share_Price\"><\/span><strong>What is the current ALIVUS Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ALIVUS Share Price is Rs 1,433.95. It gained Rs 82.70 from the previous close of Rs 1,351.25, which makes today\u2019s session a clear same-day price rise. The previous close was Rs 1,351.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Glenmark_Life_Sciences_Ltd\"><\/span><strong>What is the market capitalisation of Glenmark Life Sciences Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glenmark Life Sciences Ltd. has a market capitalisation of Rs 16,589.49 crore. That figure shows company size in the market and helps frame ALIVUS Share Price against healthcare peers. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_ALIVUS_look_on_valuation\"><\/span><strong>How does ALIVUS look on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ALIVUS trades at a P\/E of 27.51 and P\/B of 4.76. Compared with the same-industry median P\/E of 31.21, the earnings multiple is lower, while book value multiples sit higher.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_strong_are_the_profitability_ratios_for_ALIVUS\"><\/span><strong>How strong are the profitability ratios for ALIVUS?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ALIVUS reports ROE of 18.41% and ROCE of 24.61%. Both are above the same-industry medians of 11.78% and 13.6%, giving the share price move important profitability context. ROE stands at 18.41%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_ALIVUS_compare_with_its_peers\"><\/span><strong>How does ALIVUS compare with its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Against peers such as Sun Pharma, Divi\u2019s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, ALIVUS has a smaller market cap but a lower P\/E than several larger names. Comparable listed companies include Sun Pharmaceutical Industries Ltd., Divi&#39;s Laboratories Ltd., Torrent.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_investors_track_ALIVUS_Share_Price_on_Univest\"><\/span><strong>Can investors track ALIVUS Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Univest tracks ALIVUS Share Price with live price data, fundamental ratios, shareholding pattern, 52-week levels and market insights so readers can review the stock in a single place. The previous close was Rs 1,351.25.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Life Sciences Ltd. Share Price rises to Rs 1,433.95. marking a 6.12% rise today. Market cap stands at Rs 16,589.49 crore.<\/p>\n","protected":false},"author":29,"featured_media":222861,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-222863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["222861"],"rank_math_title":["Glenmark Life Sciences Share Price Rises on Sector Metrics"],"rank_math_description":["ALIVUS Share Price rose 6.12% to Rs 1,433.95. Read the price action, valuation, sector benchmark and peer comparison for Glenmark Life Sciences."],"rank_math_focus_keyword":["ALIVUS Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Glenmark_Life_Sciences_Ltd_ALIVUS_Share_Price_Rises_612_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/222863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=222863"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/222863\/revisions"}],"predecessor-version":[{"id":222864,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/222863\/revisions\/222864"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/222861"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=222863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=222863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=222863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}